Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 219-221

  Vyarvelska, Iryna ^a   Rosen, Barry ^a   Narod, Steven A ^b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; BLEEDING; BRCA2 GENE; BREAST CANCER; CANCER GENETICS; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; HUMAN; INFECTIOUS COMPLICATION; INTESTINE INJURY; MEDICAL SPECIALIST; MINIMALLY INVASIVE SURGERY; NOTE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OVARIECTOMY; OVARY CANCER; PELVIC PAIN; PERITONEUM CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE; UNIVERSITY HOSPITAL; URINARY TRACT INJURY; UTERINE CERVIX CANCER; VAGINAL HYSTERECTOMY; VENOUS THROMBOEMBOLISM;

FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HUMANS; HYSTERECTOMY; MUTATION; OVARIECTOMY; PRACTICE GUIDELINES AS TOPIC; SALPINGECTOMY; UTERINE NEOPLASMS;

EID: 84905579952     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.05.020     Document Type: Editorial

References (16)

1. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2 2006 Jul 12 185 192
2. Amy Finch, Jan Lubinski, Pal Moller, Christian F. Singer, Beth Karlan, and Leigha Senter et al. The impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation J Clin Oncol 32 2014 1547 1553
3. Y. Segev, J. Iqbal, J. Lubinski, J. Gronwald, H.T. Lynch, and P. Moller et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study Gynecol Oncol 130 2013 127 131
4. Canadian Cancer Society's Advisory Committee on Cancer Statistics Canadian Cancer Statistics 2013 2013 Canadian Cancer Society Toronto, ON
5. W. Reitsma, M.J. Mourits, G.H. de Bock, and H. Hollema Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers Mod Pathol 26 2013 572 578
6. D. Thompson, and D.F. Easton Breast Cancer Linkage C. Cancer incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 2002 1358 1365
7. O. Lavie, A. Ben-Arie, Y. Segev, J. Faro, F. Barak, and N. Haya et al. BRCA germline mutations in women with uterine serous carcinoma-still a debate Int J Gynecol Cancer 20 2010 1531 1534
8. K.P. Pennington, T. Walsh, M. Lee, C. Pennil, A.P. Novetsky, and K.J. Agnew et al. BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma Cancer 119 2013 332 338
9. R. Goshen, W. Chu, L. Elit, T. Pal, J. Hakimi, and I. Ackerman et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 79 2000 477 481
10. V. Beral, D. Bull, and G. Reeves Million Women Study C. Endometrial cancer and hormone-replacement therapy in the Million Women Study Lancet 365 2005 1543 1551
11. A. Eisen, J. Lubinski, J. Gronwald, P. Moller, H.T. Lynch, and J. Klijn et al. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers J Natl Cancer Inst 100 19 2008 Oct 1 1361 1367
12. T.R. Rebbeck, T. Friebel, T. Wagner, H.T. Lynch, J.E. Garber, and M.B. Daly et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 23 31 Nov 1 2005 7804 7810 [Epub 2005 Oct 11]
13. D.L. Clarke-Pearson, and E.J. Geller Complications of hysterectomy Obstet Gynecol 121 3 Mar 2013 654 673
14. P.J. Hanwright, L.M. Mioton, M.S. Thomassee, K.Y. Bilimoria, J. Van Arsdale, and E. Brill et al. Risk profiles and outcomes of total laparoscopic hysterectomy compared with laparoscopically assisted vaginal hysterectomy Obstet Gynecol 121 4 Apr 2013 781 787
15. T.E. Nieboer, N. Johnson, A. Lethaby, E. Tavender, E. Curr, and R. Garry et al. Surgical approach to hysterectomy for benign gynaecological disease Cochrane Database Syst Rev 3 Jul 8 2009 CD003677
16. Statistics Canada. 2013. Canada (table). Health Profile. Statistics Canada Catalogue no. 82-228-XWE. Ottawa. Released December 12, 2013. http://www12.statcan.gc.ca/health-sante/82-228/index.cfm?Lang=E. (accessed March 11, 2014).